Research Study Search Tool

Use our HBOC Research Search tool to find and participate in research focused on hereditaty cancers. Need assistance getting started?

Research & Clinical Trials > Study Search Tool > Men at High Genetic Risk for Prostate Cancer

Men at High Genetic Risk for Prostate Cancer

This study is open to:
  • Men, 30 to 75 years old without prostate cancer, who have tested positive for BRCA1, BRCA2, HOXB13, ATM, NBN, TP53, Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM), CHEK2, PALB2, RAD51D, or FANCA.
  • Genetic testing is not offered.
This study is not open to:
  • Men who have already been diagnosed with prostate cancer
Men at High Genetic Risk for Prostate Cancer

Men at High Genetic Risk for Prostate Cancer

Clinicaltrials.gov identifier:
NCT03805919

Prevention:
Prostate

Study Contact Information

Anna Couvillon, Nurse Practitioner
By phone: (240) 858-3148
or by email 

About the Study

The National Cancer Institute recently opened a clinical trial for prostate cancer screening in men who are at high risk for prostate cancer due to an inherited mutation. 

View the study on ClinicalTrials.gov or contact Anna Couvillon, NP at: (240) 858-3148 or by email. 

What the Study Entails

  • Screening MRI of the prostate every 2 years
  • Annual PSA blood test
  • Biopsy of the prostate if any MRIs are abnormal
  • No cost for study-related tests or procedures
  • No cost for travel
  • Clinical information will be shared with you and your doctor, if you choose
  • Genetic testing is not offered as part of the study

Study Lead Investigator

William L Dahut, MD, National Cancer Institute (NCI)

Study Site

The National Institutes of Health (NIH), Clinical Center
Bethesda, MD in the Washington, DC metro area
NIH can cover the cost of travel for participants

 

FORCE:Facing Our Risk of Cancer Empowered